These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34116591)

  • 21. Overall haemostasis potential assays performed in thrombophilic plasma: the effect of preactivating protein C and antithrombin.
    Andresen MS; Iversen N; Abildgaard U
    Thromb Res; 2002 Dec; 108(5-6):323-8. PubMed ID: 12676193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory investigation of thrombophilia.
    Tripodi A; Mannucci PM
    Clin Chem; 2001 Sep; 47(9):1597-606. PubMed ID: 11514392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein S testing in patients with protein S deficiency, factor V Leiden, and rivaroxaban by North American Specialized Coagulation Laboratories.
    Smock KJ; Plumhoff EA; Meijer P; Hsu P; Zantek ND; Heikal NM; Van Cott EM
    Thromb Haemost; 2016 Jul; 116(1):50-7. PubMed ID: 27075008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality assurance issues and interpretation of assays.
    Mackie I; Cooper P; Kitchen S
    Semin Hematol; 2007 Apr; 44(2):114-25. PubMed ID: 17433904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need.
    Douxfils J; Morimont L; Delvigne AS; Devel P; Masereel B; Haguet H; Bouvy C; Dogné JM
    Clin Chem Lab Med; 2020 Jan; 58(2):294-305. PubMed ID: 31444961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
    Favaloro EJ; Mirochnik O; McDonald D
    Br J Biomed Sci; 1999; 56(1):23-33. PubMed ID: 10492912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for activated protein C resistance before oral contraceptive treatment: a pilot study.
    Palareti G; Legnani C; Frascaro M; Flamigni C; Gammi L; Gola G; Fuschini G; Coccheri S
    Contraception; 1999 May; 59(5):293-9. PubMed ID: 10494482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a tissue factor dependent factor V assay to detect factor V Leiden: demonstration of high sensitivity and specificity for a generally applicable assay for activated protein C resistance.
    Liebman HA; Sutherland D; Bacon R; McGehee W
    Br J Haematol; 1996 Dec; 95(3):550-3. PubMed ID: 8943900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis of thrombophilia]].
    Kemkes-Matthes B
    Zentralbl Chir; 2001 Jun; 126(6):433-7. PubMed ID: 11446062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays. A multicentre French GEHT study.
    Gouin-Thibault I; Flaujac C; Delavenne X; Quenet S; Horellou MH; Laporte S; Siguret V; Lecompte T
    Thromb Haemost; 2014 Feb; 111(2):240-8. PubMed ID: 24172843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.
    Schöni R; Quehenberger P; Wu JR; Wilmer M
    Thromb Res; 2007; 119(1):17-26. PubMed ID: 16934314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus.
    Male C; Mitchell L; Julian J; Vegh P; Joshua P; Adams M; David M; Andrew ME
    Blood; 2001 Feb; 97(4):844-9. PubMed ID: 11159506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A modified functional global test to measure protein C, protein S activities and the activated protein C-resistance phenotype.
    Gemmati D; Serino ML; Scapoli GL
    Thromb Res; 1998 Nov; 92(3):141-8. PubMed ID: 9806366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma testing experience with the ACL TOP hemostasis testing system.
    Ho DK; Lollo M; Reyes M; Garvey MB
    Lab Hematol; 2006; 12(4):217-21. PubMed ID: 17118773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of activated protein C resistance in anticoagulated and lupus positive patients.
    Ivey LM; Thom JY; Ivey JG; Baker RI
    Blood Coagul Fibrinolysis; 2000 Jul; 11(5):439-45. PubMed ID: 10937805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of Inherited Thrombophilia Screening in Adult Kidney Transplant Recipients.
    Dhouha B; Hela B; Lilia BF; Sarra H; Karim ZM; Neila BR
    Exp Clin Transplant; 2021 Mar; 19(3):212-216. PubMed ID: 33535938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure.
    Tal J; Schliamser LM; Leibovitz Z; Ohel G; Attias D
    Hum Reprod; 1999 Jun; 14(6):1624-7. PubMed ID: 10357988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Activated protein C resistance as a cause of thrombophilia].
    Ruiz-Argüelles GJ
    Rev Invest Clin; 1996; 48(3):223-9. PubMed ID: 8966383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long-term within- and between-laboratory variability for assay of antithrombin, and proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT Foundation.
    Meijer P; Kluft C; Haverkate F; De Maat MP
    J Thromb Haemost; 2003 Apr; 1(4):748-53. PubMed ID: 12871411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance to activated protein C and low levels of protein S activity in nine thrombophilic families: a correct diagnosis.
    Gemmati D; Serino ML; Verzola I; Mari R; Moratelli S; Ballerini G
    Blood Coagul Fibrinolysis; 1997 Mar; 8(2):118-23. PubMed ID: 9518043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.